ArticleRheumatology and therapy2024

Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.

Andrea Rubbert-Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.